Efficacy and flexibility of SIRT with SIRSpheres® for treatment of HCC and liver metastases from mCRC raised at SUMM90YT conference

This four-page supplement shares insights given by key opinion leaders in selective internal radiation therapy (SIRT) using SIR-Spheres Y-90 resin microspheres (Sirtex Medical). Taking place at the SUMM90YT conference (23 February, Frankfurt, Germany), hosted by Sirtex, the meeting featured multidisciplinary discussion and debate on patient selection in hepatocellular carcinoma (HCC) and metastatic liver tumours from primary colorectal cancer (mCRC) refractory to or intolerant of chemotherapy, and technical advancements to date.